AI-generated summary
The authors studied photobiomodulation with an 830 nm near-infrared laser (TINI device) for chronic high-frequency tinnitus, using mouse experiments and a randomized trial. In mice, treatment was associated with reduced behavioral signs of tinnitus and reversal of a molecular change, with p < 0.05. In the clinical trial, tinnitus scores did not differ significantly from the sham group, though questionnaires improved after treatment compared with before.
- Participants
- 56
- Who or what was studied
- Mice (28) in preliminary animal experiments and adults with chronic high-frequency tinnitus (56) in a randomized trial
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The authors report that clinical effectiveness remains unclear, and further research is needed to optimize treatment parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Tinnitus, Photobiomodulation therapy, Photobiomodulation, Near-infrared, Laser, Randomized controlled trial, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.